|
|
|
By M. Witcher, Ph.D., biopharma operations subject matter expert | Successfully developing and manufacturing biopharmaceuticals depends on identifying, analyzing, and managing a wide variety of risks. This article presents a novel alternative risk analysis approach that provides a simple, easy, and effective method for quickly and efficiently modeling and analyzing any risk. |
|
|
|
|
| Accelerated Monoclonal Antibody Development | Webinar | MilliporeSigma | Hear from some of the experts who were instrumental in developing the accelerated mAb development program and work with biotech companies on a daily basis to accelerate their production timelines. |
|
|
|
|
|
|
|
|
|
